Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/ <scp>mL</scp> in people with type 2 diabetes in China: A post‐hoc analysis of the <scp>INITIATION</scp> study
Gla-300 improved glycaemic control with a low risk of hypoglycaemia in Chinese people with T2D across all ages and disease durations, including older individuals and those with long-standing diabetes.
Authors
- Liming Chen (ORCID: https://orcid.org/0000-0001-6171-3432)
- Caixian Yang (ORCID: https://orcid.org/0000-0002-7228-1599)
- Lei Kang (ORCID: https://orcid.org/0000-0002-6239-1727)
- BINHONG WEN
- H Liu
- Xiaohong Wu
- Hailong Wan
- Weiwei Liu
- Qiu Zhang
- Qin Du
- Minlu Zhang
- Binhong Duan
- Jie Han
Institutions
- Weifang Medical University (CN)
- Anhui Medical University (CN)
- Liaoning Provincial People's Hospital (CN)
- Weifang People's Hospital (CN)
- Heilongjiang Provincial Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Sanofi (China) (CN)
- Jiangjin Central Hospital (CN)
- Hangzhou Medical College (CN)
- Tianjin Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1111/dom.70420
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi